These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9167466)

  • 21. An analysis of HELLP syndrome cases: does platelet count predict adverse maternal and fetal outcomes in women with HELLP syndrome?
    Yucesoy G; Cakiroglu Y; Bodur H; Ozkan S; Tan T
    Arch Gynecol Obstet; 2011 May; 283(5):941-5. PubMed ID: 20422420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HELLP syndrome is associated with an increased inflammatory response, which may be inhibited by administration of prednisolone.
    van Runnard Heimel PJ; Kavelaars A; Heijnen CJ; Peters WH; Huisjes AJ; Franx A; Bruinse HW
    Hypertens Pregnancy; 2008; 27(3):253-65. PubMed ID: 18696354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipopolysaccharide-binding protein as marker of fetal inflammatory response syndrome after preterm premature rupture of membranes.
    Pavcnik-Arnol M; Lucovnik M; Kornhauser-Cerar L; Premru-Srsen T; Hojker S; Derganc M
    Neonatology; 2014; 105(2):121-7. PubMed ID: 24335151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal hemolysis, elevated liver enzymes, low platelet count, and neonatal outcome.
    Harms K; Rath W; Herting E; Kuhn W
    Am J Perinatol; 1995 Jan; 12(1):1-6. PubMed ID: 7710566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [HELLP syndrome. Severe consequence of hypertensive disease induced by pregnancy].
    Rojas-Poceros G; Viveros-Rentería E; Fernández-Castro E; Esparza-Iturbide JA; Cabra-Zurita R; Kably-Ambe A
    Ginecol Obstet Mex; 1996 Dec; 64():523-7. PubMed ID: 9019433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The influence of delivery and perinatal risk factors on the concentration of cystatine C in umbilical cord blood].
    Jedrasiak U; Grygalewicz J
    Pol Merkur Lekarski; 2007 Aug; 23(134):110-5. PubMed ID: 18044340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HELLP syndrome: an atypical presentation.
    Stella CL; Malik KM; Sibai BM
    Am J Obstet Gynecol; 2008 May; 198(5):e6-8. PubMed ID: 18342825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seeking the mechanism(s) of action for corticosteroids in HELLP syndrome: SMASH study.
    Wallace K; Martin JN; Tam Tam K; Wallukat G; Dechend R; Lamarca B; Owens MY
    Am J Obstet Gynecol; 2013 May; 208(5):380.e1-8. PubMed ID: 23380266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acid-base status of the newborn in relation to cord blood serum creatine kinase isoenzymes' activities.
    Nikliński W; Jóźwik M; Pałynyczko Z; Bartnicki J; Urban J
    Biomed Biochim Acta; 1989; 48(2-3):S200-3. PubMed ID: 2730609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women.
    Ibdah JA; Bennett MJ; Rinaldo P; Zhao Y; Gibson B; Sims HF; Strauss AW
    N Engl J Med; 1999 Jun; 340(22):1723-31. PubMed ID: 10352164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered lipid metabolism in preeclampsia and HELLP syndrome: links to enhanced platelet reactivity and fetal growth.
    Wetzka B; Winkler K; Kinner M; Friedrich I; März W; Zahradnik HP
    Semin Thromb Hemost; 1999; 25(5):455-62. PubMed ID: 10625202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fetal thrombocytopenia and its relation to maternal thrombocytopenia.
    Burrows RF; Kelton JG
    N Engl J Med; 1993 Nov; 329(20):1463-6. PubMed ID: 8413457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HELLP syndrome: understanding and management of a pregnancy-specific disease.
    Aloizos S; Seretis C; Liakos N; Aravosita P; Mystakelli C; Kanna E; Gourgiotis S
    J Obstet Gynaecol; 2013 May; 33(4):331-7. PubMed ID: 23654309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neonatal outcome in pregnancies after preterm delivery for HELLP syndrome.
    Aslan H; Gul A; Cebeci A
    Gynecol Obstet Invest; 2004; 58(2):96-9. PubMed ID: 15159596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maternal and neonatal outcome of pregnancies complicated with maternal HELLP syndrome.
    Raval DS; Co S; Reid MA; Pildes R
    J Perinatol; 1997; 17(4):266-9. PubMed ID: 9280089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Misdiagnosis of a normal fetal platelet count after coagulation of intrapartum scalp samples in autoimmune thrombocytopenic purpura.
    Moise KJ; Patton DE; Cano LE
    Am J Perinatol; 1991 Sep; 8(5):295-6. PubMed ID: 1760060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low levels of protein Z are associated with HELLP syndrome and its severity.
    Kaygusuz I; Firatli-Tuglular T; Toptas T; Ugurel V; Demir M
    Clin Appl Thromb Hemost; 2011 Apr; 17(2):214-9. PubMed ID: 20460354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The HELLP syndrome: its association with unexplained elevation of MSAFP and MShCG in the second trimester.
    Morssink LP; Heringa MP; Beekhuis JR; De Wolf BT; Mantingh A
    Prenat Diagn; 1997 Jul; 17(7):601-6. PubMed ID: 9249859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is there a diurnal pattern in the clinical symptoms of HELLP syndrome?
    Koenen SV; Huisjes AJ; Dings J; van der Graaf Y; Visser GH; Bruinse HW
    J Matern Fetal Neonatal Med; 2006 Feb; 19(2):93-9. PubMed ID: 16581604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short- and long-term outcome of infants born after maternal (pre)-eclampsia, HELLP syndrome and thrombophilia: a retrospective, cohort study.
    Boomsma JM; van Lingen RA; van Eyck J; Tamminga P; Kollen BJ; van Elburg RM
    Eur J Obstet Gynecol Reprod Biol; 2010 Nov; 153(1):47-51. PubMed ID: 20673607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.